Dominic R. Cundari's most recent trade in DiaMedica Therapeutics Inc was a trade of 15,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc | Dominic R. Cundari | Chief Commercial Officer | 01 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
DiaMedica Therapeutics Inc | Dominic R. Cundari | Chief Commercial Officer | 01 Jun 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | ||
DiaMedica Therapeutics Inc | Dominic R. Cundari | Chief Commercial Officer | 01 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | ||
DiaMedica Therapeutics Inc | Dominic R. Cundari | Chief Commercial Officer | 01 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |